TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
K. Szymańska, L. E. Moore, N. Rothman, W. H. Chow, F. Waldman, E. Jaeger, T. Waterboer, L. Foretova, M. Navratilova, V. Janout, H. Kollarova, D. Zaridze, V. Matveev, D. Mates, N. Szeszenia-Dabrowska, I. Holcatova, V. Bencko, F. Le Calvez-Kelm, S. Villar, M. PawlitaP. Boffetta, P. Hainaut, P. Brennan
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe'. Together they form a unique fingerprint.